Psychiatr. praxi. 2022;23(1):31-34 | DOI: 10.36290/psy.2022.005

Possibilities of pharmacotherapy of postpartum depression while maintaining lactation

MUDr. Antonín Šebela, Ph.D.1, 2
1 Národní ústav duševního zdraví, Klecany
2 3. lékařská fakulta, Univerzita Karlova, Praha

The period of pregnancy and postpartum is a time of challenge for all parents, and mental health disorders greatly complicate the situation. Depression is one of the most common mental disorders that can affect a woman after childbirth. Decisions about pharmacotherapy of mental disorders in pregnancy and lactation are a source of uncertainty in clinical practice. However, knowledge about the safety of antidepressants during breastfeeding is evolving dynamically, and according to current knowledge, we have a choice of several antidepressants that are considered compatible with breastfeeding. The communication is accompanied by a case study.

Keywords: postpartum depression, antidepressants, breastfeeding, pharmacotherapy.

Published: April 8, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šebela A. Possibilities of pharmacotherapy of postpartum depression while maintaining lactation. Psychiatr. praxi. 2022;23(1):31-34. doi: 10.36290/psy.2022.005.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Howard LM, Piot P, Stein. No health without perinatal mental health. Lancet. 2014;384(9956):1723-1724. Go to original source... Go to PubMed...
    2. Woody CA, Ferrari AJ, Siskind DJ, Whiteford HA, Harris MG. A systematic review and meta­‑regression of the prevalence and incidence of perinatal depression. J Affect Disord. 2017 Sep;219:86-92. Go to original source... Go to PubMed...
    3. Fawcett EJ, Fairbrother N, Cox ML, White IR, Fawcett JM. The Prevalence of Anxiety Disorders During Pregnancy and the Postpartum Period: A Multivariate Bayesian Meta­‑Analysis. J Clin Psychiatry. 2019 Jul 23;80(4):18r12527. Go to original source... Go to PubMed...
    4. Sebela A, Byatt N, Formanek T, Winkler P. Prevalence of mental disorders and treatment gap among Czech women during paid maternity or parental leave. Arch Womens Ment Health. 2021 Apr;24(2):335-338. Go to original source... Go to PubMed...
    5. Howard LM, Khalifeh H. Perinatal mental health: a review of progress and challenges. World Psychiatry. 2020 Oct;19(3):313-327. Go to original source... Go to PubMed...
    6. Sambrook Smith M, Lawrence V, Sadler E, Easter A. Barriers to accessing mental health services for women with perinatal mental illness: systematic review and meta­‑synthesis of qualitative studies in the UK. BMJ Open. 2019 Jan 24;9(1):e024803. Go to original source... Go to PubMed...
    7. Appleby L, Kumar Ch, Warner R. Perinatal psychiatry. International Review of Psychiatry. 1996;8(1):5-7. Go to original source...
    8. Ross­‑Davie M, Elliot S, Sakara A, Green L. A Public Health Role In Perinatal Mental Health: Are Midwives Ready? British Journal of Midwifery. 2006;14(6):330-334. Go to original source...
    9. Mohr P. Farmakoterapie úzkostných poruch a nespavosti v graviditě a laktaci anxiolytiky a hypnotiky. Psychiatrie. 2002;6(Suppl. 2):22-28.
    10. Seifertová D, Mohr P, Strunzová V, Čepický P. Léčba psychofarmaky v těhotenství a laktaci. Psychiatrie pro praxi. 2007;3:118-124.
    11. Šebela A, Hanka J, Goetz M, Mohr P. Psychofarmaka v těhotenství a jejich dopad na neurobehaviorální vývoj dítěte II.: Antipsychotika, stabilizátory nálady, anxiolytika. Psychiatrie. 2017;21(4):195-203.
    12. Šebela A, Hanka J, Mohr P. Etiologie, rizikové faktory a metody prevence poporodní deprese. Česká gynekologie. 2018;83(6):468-473. Go to PubMed...
    13. Šebela A, Hanka J, Mohr P. Duševní onemocnění v poporodním období: specifika a farmakoterapie. Část I: deprese, úzkostné poruchy, poruchy spánku a ADHD. Psychiatrie pro praxi. 2019;20(1):21-25. Go to original source...
    14. Bauer A, Knapp M, Parsonage M. Lifetime costs of perinatal anxiety and depression. J Affect Disord. 2016 Mar 1;192:83-90. Go to original source... Go to PubMed...
    15. Luca DL, Margiotta C, Staatz C, Garlow E, Christensen A, Zivin K. Financial Toll of Untreated Perinatal Mood and Anxiety Disorders Among 2017 Births in the United States. Am J Public Health. 2020 Jun;110(6):888-896. Go to original source... Go to PubMed...
    16. Yelland JS, Sutherland GA, Wiebe JL, Brown SJ. A national approach to perinatal mental health in Australia: exercising caution in the roll­‑out of a public health initiative. Med J Aust. 2009 Sep 7;191(5):276-9. Go to original source... Go to PubMed...
    17. Šebela A, Martan S, Kubrichtová V, Hanka J, Mohr P. Prevence perinatálních duševních poruch: současná situace ve světě a v České republice. Gyn Por. 2019;3(3):1-4.
    18. ACOG Committee Opinion No. 757: Screening for Perinatal Depression. Obstet Gynecol. 2018 Nov;132(5):e208-e212. Go to original source... Go to PubMed...
    19. Byatt N, Xu W, Levin LL, Moore Simas TA. Perinatal depression care pathway for obstetric settings. Int Rev Psychiatry. 2019 May;31(3):210-228. Go to original source... Go to PubMed...
    20. Uguz F. A New Safety Scoring System for the Use of Psychotropic Drugs During Lactation. Am J Ther. 2021 Jan­‑Feb 01;28(1):e118-e126. Go to original source... Go to PubMed...
    21. Huang R, Yan C, Tian Y, Lei B, Yang D, Liu D, Lei J. Effectiveness of peer support intervention on perinatal depression: A systematic review and meta­‑analysis. J Affect Disord. 2020 Nov 1;276:788-796. Go to original source... Go to PubMed...
    22. Milgrom J, Danaher BG, Gemmill AW, Holt C, Holt CJ, Seeley JR, Tyler MS, Ross J, Ericksen J. Internet Cognitive Behavioral Therapy for Women With Postnatal Depression: A Randomized Controlled Trial of MumMoodBooster. J Med Internet Res. 2016 Mar 7;18(3):e54. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.